  |
Lægemiddelstofklassifikation ATC |
M | ||
  |
Antineoplastiske og immunomodulerende midler |
ML | ||
  |
antineoplastiske stoffer |
ML01 | ||
 |
proteinkinasehæmmere |
ML01E | ||
 |
andre proteinkinasehæmmere |
ML01EX | ||
 |
sunitinib |
ML01EX01 | ||
 |
sorafenib |
ML01EX02 | ||
 |
pazopanib |
ML01EX03 | ||
 |
vandetanib |
ML01EX04 | ||
 |
regorafenib |
ML01EX05 | ||
 |
masitinib |
ML01EX06 | ||
 |
cabozantinib |
ML01EX07 | ||
 |
lenvatinib |
ML01EX08 | ||
 |
nintedanib |
ML01EX09 | ||
 |
midostaurin |
ML01EX10 | ||
 |
quizartinib |
ML01EX11 | ||
 |
larotrectinib |
ML01EX12 | ||
 |
gilteritinib |
ML01EX13 | ||
 |
entrectinib |
ML01EX14 | ||
 |
pexidartinib |
ML01EX15 | ||
 |
capmatinib |
ML01EX17 | ||
 |
avapritinib |
ML01EX18 | ||
 |
ripretinib |
ML01EX19 | ||
 |
tepotinib |
ML01EX21 | ||
 |
selpercatinib |
ML01EX22 | ||
 |
pralsetinib |
ML01EX23 | ||
 |
surufatinib |
ML01EX24 | ||
 |
umbralisib |
ML01EX25 | ||
 |
sitravatinib |
ML01EX26 | ||
 |
capivasertib |
ML01EX27 | ||
 |
repotrectinib |
ML01EX28 |
TEXT